PLX-4720

Catalog No. A10002

PLX-4720是一种有效的,选择性的B-RafV600E抑制剂,无细胞试验中IC50为13 nM,同样有效地作用于c-Raf-1(Y340D和Y341D突变型),作用于B-RafV600E比作用于野生型B-Raf选择性高10倍。
Catalog Num A10002
M. Wt 413.8
Formula C17H14ClF2N3O3S
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 918505-84-7
Synonyms PLX4720
SMILES CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)Cl)F
PLX-4720是一种有效的,选择性的B-RafV600E抑制剂,无细胞试验中IC50为13 nM,同样有效地作用于c-Raf-1(Y340D和Y341D突变型),作用于B-RafV600E比作用于野生型B-Raf选择性高10倍。
Targets
Target Value
C-Raf-1(Y340D/Y341D)IC50: 6.7nM
B-Raf(V600E)IC50: 13nM
BRKIC50: 130nM
B-RafIC50: 160nM
FRKIC50: 1.3μM
CSKIC50: 1.5μM
SrcIC50: 1.7μM
FAKIC50: 1.7μM
FGFRIC50: 1.9μM
KDRIC50: 2.3μM
HGKIC50: 2.8μM
CSF-1RIC50: 3.3μM
AuroraAIC50: 3.4μM
In vitro (25°C) DMSO 81 mg/mL (195.73 mM)
Water Insoluble
Ethanol Insoluble
In vivo 2% DMSO+50% PEG 300+5% Tween 80+ddH2O 4 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 24.17 mL 120.83 mL 241.66 mL
0.5 mM 4.83 mL 24.17 mL 48.33 mL
1 mM 2.42 mL 12.08 mL 24.17 mL
5 mM 0.48 mL 2.42 mL 4.83 mL

*The above data is based on the productmolecular weight 413.8. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.